Windtree Therapeutics INC /De
Warrington, US
Biotech
Founders & leadership
MB
Mary B. TempletonExecutive Officer
CE
Craig E. FraserExecutive Officer, Director
LA
Lawrence A. WeinsteinExecutive Officer
KE
Kathryn E. ColeExecutive Officer
ME
Marvin E. RosenthaleDirector
JM
Joseph M. MahadyDirector
BA
Bruce A. PeacockDirector
JR
John R. LeoneDirector
JA
John A. TattoryExecutive Officer
GE
George E. CoxExecutive Officer
SA
Steven A. SimonsonExecutive Officer
Reported raises · per SEC filings
Form D private placements$26.4MraisedDec 2019 · 5 investors · Biotechnology
Rule 506(b)$1MraisedJan 2019 · 1 investors · Biotechnology
Rule 506(b)$2.6MraisedJul 2018 · 1 investors · Biotechnology
Rule 506(b)$1.5MraisedJul 2018 · 1 investors · Biotechnology
Rule 506(b)$10.3MraisedNov 2017 · 17 investors · Biotechnology
Rule 506(b)$10.5MraisedFeb 2017 · 17 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.